Hargreaves Lansdown GroupMay 6 2022

Hargreaves a 'buy' despite ‘short-term pain’: analyst

twitter-iconfacebook-iconlinkedin-iconmail-iconprint-icon
Search supported by
Hargreaves a 'buy' despite ‘short-term pain’: analyst
Charlie Bibby/FT
comment-speech

Hargreaves Lansdown is still a stock worth buying despite the fact its shares have fallen around 40 per cent over the past six months.

A service from the Financial Times
For unlimited access to FTAdviser content...

Register now for free

  • Read the latest news and views from the world of financial advice
  • Never miss a story - sign up to our email alerts
  • Bank CPD while you read
Have an account? Sign In